These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14563954)

  • 1. 15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma.
    Okano H; Shiraki K; Inoue H; Yamanaka Y; Kawakita T; Saitou Y; Yamaguchi Y; Enokimura N; Yamamoto N; Sugimoto K; Murata K; Nakano T
    Lab Invest; 2003 Oct; 83(10):1529-39. PubMed ID: 14563954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
    Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins.
    Piva R; Gianferretti P; Ciucci A; Taulli R; Belardo G; Santoro MG
    Blood; 2005 Feb; 105(4):1750-8. PubMed ID: 15498850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells.
    Lee DR; Kwon CH; Park JY; Kim YK; Woo JS
    Toxicology; 2009 Apr; 258(1):17-24. PubMed ID: 19167456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma augments tumor necrosis factor family-induced apoptosis in hepatocellular carcinoma.
    Okano H; Shiraki K; Inoue H; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Fujikawa K; Murata K; Nakano T
    Anticancer Drugs; 2002 Jan; 13(1):59-65. PubMed ID: 11914642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.
    Nencioni A; Lauber K; Grünebach F; Van Parijs L; Denzlinger C; Wesselborg S; Brossart P
    J Immunol; 2003 Nov; 171(10):5148-56. PubMed ID: 14607914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
    Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
    Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S; Rattan R; Singh AK; Singh I
    J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
    Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
    Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
    Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.
    Straus DS; Pascual G; Li M; Welch JS; Ricote M; Hsiang CH; Sengchanthalangsy LL; Ghosh G; Glass CK
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4844-9. PubMed ID: 10781090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Ward C; Dransfield I; Murray J; Farrow SN; Haslett C; Rossi AG
    J Immunol; 2002 Jun; 168(12):6232-43. PubMed ID: 12055237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.
    Fujita M; Tohji C; Honda Y; Yamamoto Y; Nakamura T; Yagami T; Yamamori M; Okamura N
    Int J Med Sci; 2012; 9(7):555-66. PubMed ID: 22991494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
    Kim HS; Chang I; Kim JY; Choi KH; Lee MS
    Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
    Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
    Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
    J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
    Emi M; Maeyama K
    Biochem Pharmacol; 2004 Apr; 67(7):1259-67. PubMed ID: 15013841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
    Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PPARgamma ligand, 15-Deoxy-Delta12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells.
    Okano H; Shiraki K; Inoue H; Kawakita T; Deguchi M; Sugimoto K; Sakai T; Murata K; Nakano T; Enjoji M
    Int J Mol Med; 2003 Dec; 12(6):867-70. PubMed ID: 14612959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.